Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-17T12:03:06.785Z Has data issue: false hasContentIssue false
  • English
  • Français

The changing landscape of oropharyngeal cancer management

Published online by Cambridge University Press:  29 November 2016

D Hamilton ,
M K Khan ,
J O'hara  and
V Paleri
D Hamilton*
Affiliation:
ENT Department, Freeman Hospital, Newcastle upon Tyne, UK
M K Khan
Affiliation:
ENT Department, Freeman Hospital, Newcastle upon Tyne, UK
J O'hara
Affiliation:
ENT Department, Freeman Hospital, Newcastle upon Tyne, UK
V Paleri
Affiliation:
ENT Department, Freeman Hospital, Newcastle upon Tyne, UK
*
Address for correspondence: Mr David Hamilton, ENT Department, Freeman Hospital, High Heaton, Newcastle upon Tyne NE7 7DN, UK E-mail: david.hamilton@ncl.ac.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Oropharyngeal cancer is increasing in prevalence in the UK and this is thought to be due to the emergence of disease related to human papilloma virus.

Method:

A literature review was conducted on the diagnosis and latest management of oropharyngeal cancer.

Results:

In non-smokers, human papilloma virus related disease is thought to have better outcomes, but this casts doubt on previous research which did not stratify patients according to human papilloma virus status. However, this theory provides a route for researchers to risk stratify and de-escalate treatments, and hence reduce treatment burden. In addition, the emergence of minimally invasive transoral techniques allows surgeons to remove large tumours without many of the side effects associated with radical (chemo)radiotherapy.

Conclusion:

The emergence of human papilloma virus related disease and minimally invasive techniques have led the clinical and academic community to reconsider how oropharyngeal cancer is managed. Comparative and risk-stratification trials are urgently required and ongoing.

Keywords

Surgical Procedures, OperativeRobotic Surgical ProceduresLaser TherapyOropharyngeal NeoplasmsHuman Papilloma Virus
Type
Review Article
Information
The Journal of Laryngology & Otology , Volume 131 , Issue 1 , January 2017 , pp. 3 - 7
Copyright
Copyright © JLO (1984) Limited 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Cancer Research UK. Oral cancer incidence statistics, 2013. In: http://info.cancerresearchuk.org/cancerstats/types/oral/incidence [27 September 2016]Google Scholar
2 National Cancer Institute. Surveillance, Epidemiology and End Results Program, 2013. In: http://seer.cancer.gov/ [27 September 2016]Google Scholar
3 Nasman, A, Attner, P, Hammarstedt, L, Du, J, Eriksson, M, Giraud, G et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009;125:362–6Google Scholar
4 Fakhry, C, Westra, WH, Li, S, Cmelak, A, Ridge, JA, Pinto, H et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261–9CrossRefGoogle ScholarPubMed
5 Worden, FP, Kumar, B, Lee, JS, Wolf, GT, Cordell, KG, Taylor, JM et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 2008;26:3138–46Google Scholar
6 Ang, KK, Harris, J, Wheeler, R, Weber, R, Rosenthal, DI, Nguyen-Tan, PF et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35 Google Scholar
7 Gillison, ML, Zhang, Q, Jordan, R, Xiao, W, Westra, WH, Trotti, A et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012;30:2102–11Google Scholar
8 Heck, JE, Berthiller, J, Vaccarella, S, Winn, DM, Smith, EM, Shan'gina, O et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2010;39:166–81CrossRefGoogle ScholarPubMed
9 Mehanna, H, Jones, TM, Gregoire, V, Ang, KK. Oropharyngeal carcinoma related to human papillomavirus. BMJ 2010;340:c1439 Google Scholar
10 Singhi, AD, Westra, WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010;116:2166–73Google Scholar
11 O'Sullivan, B, Huang, SH, Siu, LL, Waldron, J, Zhao, H, Perez-Ordonez, B et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 2013;31:543–50CrossRefGoogle ScholarPubMed
12 Granata, R, Miceli, R, Orlandi, E, Perrone, F, Cortelazzi, B, Franceschini, M et al. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. Ann Oncol 2012;23:1832–7CrossRefGoogle ScholarPubMed
13 Parsons, JT, Mendenhall, WM, Stringer, SP, Amdur, RJ, Hinerman, RW, Villaret, DB et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 2002;94:2967–80CrossRefGoogle ScholarPubMed
14 Denis, F, Garaud, P, Bardet, E, Alfonsi, M, Sire, C, Germain, T et al. Final results of the 94–01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004;22:69–76 CrossRefGoogle ScholarPubMed
15 Abendstein, H, Nordgren, M, Boysen, M, Jannert, M, Silander, E, Ahlner-Elmqvist, M et al. Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope 2005;115:2183–92CrossRefGoogle ScholarPubMed
16 Rogers, SN, Ahad, SA, Murphy, AP. A structured review and theme analysis of papers published on ‘quality of life’ in head and neck cancer: 2000–2005. Oral Oncol 2007;43:843–68CrossRefGoogle ScholarPubMed
17 Denis, F, Garaud, P, Bardet, E, Alfonsi, M, Sire, C, Germain, T et al. Late toxicity results of the GORTEC 94–01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int J Radiat Oncol Biol Phys 2003;55:93–8Google Scholar
18 Wilson, JA, Carding, PN, Patterson, JM. Dysphagia after nonsurgical head and neck cancer treatment: patients' perspectives. Otolaryngol Head Neck Surg 2011;145:767–71CrossRefGoogle ScholarPubMed
19 Paleri, V, Patterson, J. Use of gastrostomy in head and neck cancer: a systematic review to identify areas for future research. Clin Otolaryngol 2010;35:177–89Google Scholar
20 Moor, JW, Patterson, J, Kelly, C, Paleri, V. Prophylactic gastrostomy before chemoradiation in advanced head and neck cancer: a multiprofessional web-based survey to identify current practice and to analyse decision making. Clin Oncol (R Coll Radiol) 2010;22:192–8CrossRefGoogle ScholarPubMed
21 Nutting, CM, Morden, JP, Harrington, KJ, Urbano, TG, Bhide, SA, Clark, C et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127–36CrossRefGoogle ScholarPubMed
22 Forastiere, AA, Goepfert, H, Maor, M, Pajak, TF, Weber, R, Morrison, W et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091–8CrossRefGoogle ScholarPubMed
23 Trotti, A, Pajak, TF, Gwede, CK, Paulus, R, Cooper, J, Forastiere, A et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 2007;8:613–24CrossRefGoogle ScholarPubMed
24 Huet, PC. Electrocoagulation in epitheliomas of the tonsils. Ann Otolaryngol 1951;68:433–42Google Scholar
25 Holsinger, FC, McWhorter, AJ, Ménard, M, Garcia, D, Laccourreye, O. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: I. Technique, complications, and functional results. Arch Otolaryngol Head Neck Surg 2005;131:583–91Google Scholar
26 Laccourreye, O, Hans, S, Ménard, M, Garcia, D, Brasnu, D, Holsinger, FC. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: II. An analysis of the incidence, related variables, and consequences of local recurrence. Arch Otolaryngol Head Neck Surg 2005;131:592–9.CrossRefGoogle Scholar
27 Steiner, W, Fierek, O, Ambrosch, P, Hommerich, CP, Kron, M. Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 2003;129:36–43 CrossRefGoogle ScholarPubMed
28 Haughey, BH, Hinni, ML, Salassa, JR, Hayden, RE, Grant, DG, Rich, JT et al. Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck 2011;33:1683–94CrossRefGoogle ScholarPubMed
29 O'Hara, J, Cosway, B, Muirhead, C, Leonard, N, Goff, D, Patterson, J. Transoral laser microsurgery ± adjuvant therapy versus chemoradiotherapy for stage III and IVA oropharyngeal squamous cell cancer: preliminary comparison of early swallowing outcomes. Head Neck 2015;37:1488–94CrossRefGoogle ScholarPubMed
30 Hockstein, NG, Nolan, JP, O'Malley, BW Jr, Woo, YJ. Robotic microlaryngeal surgery: a technical feasibility study using the daVinci surgical robot and an airway mannequin. Laryngoscope 2005;115:780–5CrossRefGoogle Scholar
31 O'Malley, BW Jr, Weinstein, GS, Hockstein, NG. Transoral robotic surgery (TORS): glottic microsurgery in a canine model. J Voice 2006;20:263–8Google Scholar
32 O'Malley, BW Jr, Weinstein, GS, Snyder, W, Hockstein, NG. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 2006;116:1465–72Google Scholar
33 Weinstein, GS, O'Malley, BW Jr, Snyder, W, Sherman, E, Quon, H. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 2007;133:1220–6Google Scholar
34 White, HN, Moore, EJ, Rosenthal, EL, Carroll, WR, Olsen, KD, Desmond, RA et al. Transoral robotic-assisted surgery for head and neck squamous cell carcinoma: one- and 2-year survival analysis. Arch Otolaryngol Head Neck Surg 2010;136:1248–52Google Scholar
35 Weinstein, GS, O'Malley, BW Jr, Magnuson, JS, Carroll, WR, Olsen, KD, Daio, L et al. Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope 2012;122:1701–7CrossRefGoogle ScholarPubMed
36 Cooper, JS, Pajak, TF, Forastiere, AA, Jacobs, J, Campbell, BH, Saxman, SB et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937–44CrossRefGoogle ScholarPubMed